Charles Schwab Investment Management Inc Forte Biosciences, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.07 - $1.55 $26,537 - $38,441	-24,801 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$2.02 - $3.36 $7,213 - $11,998	-3,571 Reduced 12.59%	24,801 $54,000
Q3 2021 Nov 16, 2021	BUY	$2.96 - $36.67 $2,613 - $32,379	883 Added 3.21%	28,372 $84,000
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $865,903 - $1.17 Million	27,489 New	27,489 $925,000

175K

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.